Systemic IGF-I administration attenuates the inhibitory effect of chronic arthritis on gastrocnemius mass and decreases atrogin-1 and IGFBP-3.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples